#circAHA - Twitter Hashtag

2 months ago

📢 ICYMI: New findings from a SYMPHONY-PE Trial analysis were recently published in Circulation: Cardiovascular Interventions (#CircAHA), suggesting that earlier catheter-based intervention may accelerate cardiac recovery in patients with intermediate-risk PE. Together with physicians, we’re working to advance PE care and support patient outcomes through clinical evidence generation. 🔗Read the press release: https://t.co/u4HznJtvgd #PulmonaryEmbolism #PulseThrombectomy Rx only. ISI: https://t.co/Q5HSdTIghf

0

3

2

1

479

Imperative Care Vascular

@ImpCare_Vasc

3 months ago

📊New #CircAHA publication from the SYMPHONY-PE Trial: analysis findings suggest that early treatment of intermediate-risk PE with the Symphony Thrombectomy System within 12 hours of diagnosis may be associated with greater improvements in acute hemodynamic and RV measures, with similar safety outcomes compared with treatment after 12 hours. Read the publication: https://t.co/Q5HSdTIghf Rx only. ISI: https://t.co/Q5HSdTIghf #PulmonaryEmbolism #Thrombectomy #ClinicalData

0

2

1

0

208

JakobHartvigThomsen @JakobHartvig

over 1 year ago

A proud moment for a PhD supervisor. @signeglargaard has led the TAP-it trial with conviction, enthusiasm and a lot of hard work, supported by leadership from Dr.Thune and co-investigators. Thank you for the appraisal @drjohnm #tapit #acuteheartfailure #thoracentesis #circAHA

JakobHartvig's tweet photo. A proud moment for a PhD supervisor. @signeglargaard has led the TAP-it trial with conviction, enthusiasm and a lot of hard work, supported by leadership from Dr.Thune and co-investigators.
Thank you for the appraisal @drjohnm
#tapit #acuteheartfailure #thoracentesis #circAHA https://t.co/n5cx9PVpXu

2

12

1

0

1K

Diego Segura-Rodríguez @SeguraCardio

about 2 years ago

📌Clinical Significance of Exercise Pulmonary Hypertension w/ a Negative Diastolic Stress Test(DST) for Suspected #HFpEF 🔸⬆️ mPAP/CO slope might indicate #HFpEF irrespective of the DST result #CircAHA

SeguraCardio's tweet photo. 📌Clinical Significance of Exercise Pulmonary Hypertension w/ a Negative Diastolic Stress Test(DST) for Suspected #HFpEF

🔸⬆️ mPAP/CO slope might indicate #HFpEF irrespective of the DST result

#CircAHA https://t.co/DMREoq5jxA

1

61

18

13

6K

Circulation @CircAHA

over 3 years ago

#CircAHA Cardiac Myosin Inhibition: A Targeted Therapeutic Option in Hypertrophic Cardiomyopathy #HCM New #Perspective from @AwangDukeU #AHAJournals https://t.co/FoQsmNOq1Z

CircAHA's tweet photo. #CircAHA Cardiac Myosin Inhibition: A Targeted Therapeutic Option in Hypertrophic Cardiomyopathy #HCM New #Perspective from @AwangDukeU #AHAJournals https://t.co/FoQsmNOq1Z https://t.co/9kZbpAC5ur

0

8

4

0

3K

carlosjuanatey @carlosjuanatey

over 4 years ago

Pregnancy and Spontaneous Coronary Artery Dissection: Lessons From Survivors and Nonsurvivors https://t.co/Ui0AiA9Knx #CardioTwitter #CircAHA @CardiologiaHULA @melisasantas

0

4

1

0

Makoto Hibino MD MPH PhD FACC FACS @HibinoMDMPH

over 4 years ago

Just now talked with a giant of aortic dissection in UK. This is wonderful community!! #AHA #CircAHA #Circulation on the run, the podcast will come up on March!

1

8

0

Gaetano Nucifora @GaetanoNucifora

over 5 years ago

@Dr_Santangeli @Daniele_Muser Happy to see this important multi-center study published in Circulation. Another demonstration of the clinical utility of CMR. A big thanks to all coauthors participating in this registry. #whycmr #circaha @josephselvacmr @SCMRorg @chiarabd @MCRImaging

GaetanoNucifora's tweet photo. @Dr_Santangeli @Daniele_Muser Happy to see this important multi-center study published in Circulation. Another demonstration of the clinical utility of CMR. A big thanks to all coauthors participating in this registry. #whycmr #circaha @josephselvacmr @SCMRorg @chiarabd @MCRImaging https://t.co/pF9da4sa77

1

21

4

0

Ryan Wereski @RyanWereski

over 5 years ago

Fascinating study: 8 fold increase in hs-Troponin after only 90 seconds of controlled coronary occlusion with LAD balloon Only 25% still over 99th-centile at 3 hours #CircAHA #troponin https://t.co/RkSODnhsFp

0

1

0

Susanna Larsson @LarssonSC

over 6 years ago

Our new MR study supports Lp(a) as a causal risk factor for atherosclerotic and valvular diseases but not for thrombotic disease and hemorrhagic stroke subtypes | Circulation https://t.co/jISWJHpGD8 #CircAHA @dpsg108 @amymariemason @aidanbutty @stevesphd

0

17

8

3

0

Circulation @CircAHA

over 7 years ago

Highlights from the #CircAHA family of journals #AHAJournals https://t.co/zLUHKNTAbO

0

6

5

0

Venice Arrhythmias @VArrhythmias

almost 8 years ago

Despite significant strides in our ability to treat cardiac disease over the past half a century, this remains the leading cause of death. In the Figure: The concept for app designed to identify individuals at the highest risk for an acute cardiac event. #CircAHA #VA2019

VArrhythmias's tweet photo. Despite significant strides in our ability to treat cardiac disease over the past half a century, this remains the leading cause of death. In the Figure: The concept for app designed to identify individuals at the highest risk for an acute cardiac event. #CircAHA #VA2019 https://t.co/B9cghHnc36

0

5

4

0

UAB Cardiovascular Disease @UABCardiology

over 8 years ago

Drs. Sumanth Prabhu, Garima Arora, & Pankaj Arora article: Do not assume “evidence of absence” for NTproBNP based approach to tailor therapy in HFrEF patients, #JACC, #CircAHA, #JAMAcardio https://t.co/12NiiVEuCf

0

2

0